The Tumor Lysis Syndrome
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
The tumor lysis syndrome is the most common disease-related emergency in children and adults with hematologic cancers. This review summarizes current strategies for risk assessment, prophylaxis, and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An important consideration with respect to safety in patients that may have a compromised immune system is that engineered bacterial products are likely to engage both innate and adaptive immunity in the event of release of the organism into the body following tumor lysis75, triggering inflammatory responses.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [75]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802639 · Cited by 1,759
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationTumour lysis syndrome: new therapeutic strategies and classification
Cairo, M. S., & Bishop, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05094.x · Cited by 1,076
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
Coiffier, B., Altman, A., Pui, C.-H., Younes, A., & Cairo, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0177 · Cited by 792
Self-citationCairo, M. S., Coiffier, B., Reiter, A., Younes, A., & Panel, O. B. O. T. T. E. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08143.x · Cited by 570
Goldman, S. C., Holcenberg, J. S., Finklestein, J. Z., Hutchinson, R., Kreissman, S., Johnson, F. L., Tou, C., Harvey, E., Morris, E., & Cairo, M. S. (2001) · Blood · doi:10.1182/blood.v97.10.2998 · Cited by 477
Cairo, M. S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, C. R., Michon, J., Weston, C., Perkins, S. L., Raphael, M., McCarthy, K., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036665 · Cited by 363
Pui, C.-H., Mahmoud, H. H., Wiley, J. M., Woods, G. M., Leverger, G., Camitta, B., Hastings, C., Blaney, S. M., Relling, M. V., & Reaman, G. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.697 · Cited by 361
Self-citationOral Phosphate Binders in Patients with Kidney Failure
Tonelli, M., Pannu, N., & Manns, B. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912522 · Cited by 339
Cited by
Items 701–800 of 1,000
Battah, A. A., Farouji, I., DaCosta, T. R., Ghandi, D., DaCosta, T. R., & Bains, Y. (2023) · Cureus · doi:10.7759/cureus.48024 · Cited by 1
“Tumor lysis syndrome (TLS) is a critical oncological emergency that can occur spontaneously or following the initiation of treatments such as chemotherapy, radiation, targeted immune therapy, or hormonal therapy [3].”
BackgroundKinanti, R. A., Palupi‐Baroto, R., & Sutaryo, S. (2023) · Paediatrica Indonesiana · doi:10.14238/pi63.6.2023.433-42 · Cited by 1
“26,27 However, this theory was not in agreement with our study findings.”
BackgroundResultAl-abbadi, M., & Hadidi, S. A. (2023) · JAP Academy Journal · doi:10.58877/japaj.v1i3.85 · Cited by 1
Kasai, S., Sato, E., Sakaguchi, C., & Sasaki, Y. (2024) · Internal Medicine · doi:10.2169/internalmedicine.2925-23 · Cited by 1
ANTICANCER ACTIVITY OF BEE VENOM AND ITS COMPONENTS AGAINST BREAST CANCER : A REVIEW
Taruna, T., Simran, S., & Mishra, M. (2024) · PLANT ARCHIVES · doi:10.51470/plantarchives.2024.v24.no.1.031 · Cited by 1
“…disruption refers to the process of degradation or lysis of cell membrane that causes the release of inner cellular organelles, fluid as well as genetic material outside the cell in the bloodstream either spontaneously or in response to therapy (Shehadul Islam et al ., 2017; Howard et al ., 2011).”
BackgroundThe Case | Obstructive acute renal failure due to acute uric acid nephrolithiasis
Decaestecker, A., Ydée, A., Metzger, C., Lionet, A., Barbieux, S., Laboux, T., & Pagniez, M.-S. (2024) · Kidney International · doi:10.1016/j.kint.2024.05.013 · Cited by 1
Peshin, S., Singal, S., & Moka, N. (2024) · Cureus · doi:10.7759/cureus.73573 · Cited by 1
Saluja, K. V., Arya, Y., Sukheeja, D., & Suman, C. P. (2024) · BMJ Case Reports · doi:10.1136/bcr-2024-261320 · Cited by 1
Drehmer, G. K., Piaz, I. D. S., Lazaretti, W. Y., & Ceglarek, V. M. (2024) · Revista fisio&terapia. · doi:10.69849/revistaft/ni10202411242206 · Cited by 1
Fankhauser, R. G., Lu, A., Kassim, A. A., & Biltibo, E. A. (2024) · Reports — Medical Cases Images and Videos · doi:10.3390/reports7040108 · Cited by 1
“Tumor lysis syndrome (TLS) is a potentially fatal oncologic emergency that can occur when large amounts of tumor cells are lysed and release their contents into the blood-stream [1].”
Supportive Care During Therapy for Childhood Acute Lymphoblastic Leukemia
Orgel, E., Mukkada, S. T., Denton, C. C., & Bhojwani, D. (2024) · Pediatric oncology · doi:10.1007/978-3-031-71180-0_19 · Cited by 1
Síndrome de lisis tumoral espontáneo en paciente con diagnóstico de cáncer de colon metastásico
Noguera, J. A. R., & Rincón, J. F. T. (2024) · Revista Med · doi:10.18359/rmed.7193 · Cited by 1
Yassin, M. A., Farsi, K. A., Hamad, A. A., Ghasoub, R. S., Alhuraiji, A., Mheidly, K., Yaseen, H. A., Osman, H. Y., & Trepel, M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1509074 · Cited by 1
Arikpo, K. E., Zaruwa, M. Z., Iwara, I. A., Nweze, C. C., Ajiboso, O. S. O., Joseph, B. C., Onyisi, C. O., Atiku, J. M., Abara, U. V., & Ogbu, S. C. (2025) · African Journal of Advances in Science and Technology Research · doi:10.62154/ajastr.2025.019.01027 · Cited by 1
“These metabolites, enzymes and electrolytes are prognostic biomarkers useful to monitor the progression of leukemia (Boles et al ., 1984; Kanfer et al ., 1979; Howard et al ., 2011).”
Yessayan, L. T., Tolwani, A., Heung, M., & Szamosfalvi, B. (2025) · Kidney360 · doi:10.34067/kid.0000001053 · Cited by 1
“23,24 After para-thyroidectomy, the absence of high parathyroid hormone levels shifts the balance toward osteoblast activity, promoting bone mineralization and rapid calcium and phosphate deposition into the bone matrix.”
A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL
Takizawa, J., Yoshida, I., Ogawa, Y., Toubai, T., Kusumoto, S., Watanabe, M., Ogawa, N., Satomi, N., Nishimura, Y., Honda, H., et al. (2025) · International Journal of Hematology · doi:10.1007/s12185-025-04114-w · Cited by 1
Tumor Lysis Syndrome Induced by Hormonal Therapy in Metastatic Prostate Cancer: A Case Report
Machado, M., Mourato, M., Negrão, C., Rodrigues, C., & Serra, J. T. (2025) · Cureus · doi:10.7759/cureus.98643 · Cited by 1
Feng, B., Shen, W., Cheng, S., Wang, P., & Zhang, Y. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-12485-y · Cited by 1
“Moreover, inflammation-driven tissue necrosis, such as tumor lysis, releases intracellular potassium and further suppresses this ratio [31].”
Allan, J. N. (2026) · Advances in Therapy · doi:10.1007/s12325-025-03486-z · Cited by 1
“Patients may require prophylactic medications and laboratory monitoring for TLS during ramp-up [44].”
Diallo, A. B., Faye, B. F., Touré, S. A., Bousso, E. S., Keita, M., Dieng, F., Seck, M., & Diop, S. (2026) · Advances in Hematology · doi:10.1155/ah/5090658 · Cited by 1
Tasnim, N., Khachatryan, V., Burrola-Suárez, M. A., Rahman, M. T., Rezwan, M., Khan, M., & Khan, A. (2026) · Case Reports in Oncology · doi:10.1159/000551537 · Cited by 1
“…(hyperkalemia, hyperphosphatemia, hyperuricemia, and/or hypocalcemia) occurring from 3 days before to 7 days after treatment initiation – and clinical TLS, which requires laboratory TLS plus at least one of the following: elevated creatinine, seizure, cardiac dys-rhythmia, or death [1–4].”
InfluentialTumor Lysis Syndrome in Lung Cancer Patients: A Review of the Literature
Siddiqui, Z., Schab, A., Paracha, A., Abid, A., Rifai, K., Huba, M., Arshad, M., Paracha, M., Durrani, U. S., Nair, H., et al. (2026) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2026.27.4.1179 · Cited by 1
Yuan, F., Zhao, X., Lin, X., & Wang, J. (2026) · Leukemia Research · doi:10.1016/j.leukres.2026.108232 · Cited by 1
Pettit, S. M., & Liu, N. (2026) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyag062 · Cited by 1
Teoh, S. K., Wong, Y. S., Ganapathy, S., & Shah, A. A. S. (2026) · BMJ Case Reports · doi:10.1136/bcr-2026-272527 · Cited by 1
Zhang, X., Jin, X.-S., Gao, X.-X., Wang, S.-S., & Mo, H.-X. (2026) · Discover Oncology · doi:10.1007/s12672-026-05485-0 · Cited by 1
“The most typical example is tumor lysis syndrome (TLS)—after the rapid lysis of tumor cells, a large amount of nucleic acids are released, which are metabolized to generate excessive UA, thereby causing serious complications such as acute kidney injury [11, 12].”
Wang, M. L., Hoffmann, M. S., Wróbel, T., Trněný, M., Belada, D., Demirken, F., Panayiotidis, P. G., Jurczak, W. J., Zinzani, P. L., Keating, M., et al. (2026) · Blood · doi:10.1182/blood.2025032833 · Cited by 1
Sodium bicarbonate for metabolic acidosis
Jung, B., Neto, A. S., & Fujii, T. (2026) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001425 · Cited by 1
Ailawadhi, S., Challagulla, S., Meng, Y., Totev, T. I., Pilon, D., Diaz, L., Chen, Z., & Yang, K. (2026) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2026.2722166 · Cited by 1
Vitamin D Deficiency and Hypocalcemia in an Infant With Newly Diagnosed AML
Cook, C., Bernardo, V., Shelso, J., & Ribeiro, R. C. (2013) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31828e51cc · Cited by 1
Urgence dans les leucémies aiguës myéloïdes
Dreyfus, F. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)71847-1 · Cited by 1
Shusterman, M., Bloomgarden, N. A., Sotardi, S. T., & Shastri, A. (2015) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-015-9755-7 · Cited by 1
“en to cause life-threatening acute oliguric renal failure, cardiac arrhythmias, and seizures [13].”
BackgroundInfluentialMetabolic Disturbance in Cancer Patients
Barreto, C. M. N., Vega, M. C. M. D., de Almeida, M. S., Tadokoro, H., & de Mello, R. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-21683-6_33 · Cited by 1
Hematology–oncology emergencies
Shah, K. H., Lee, J., Medlej, K., & Weingart, S. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139523936.049 · Cited by 1
Rasburicase for Tumor Lysis Syndrome
Vishwanathan, S., Arumugarajah, A., Ortega, L. M., & Bousamra, A. (2016) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000462 · Cited by 1
“In adults, it is more commonly seen after treatment of lymphoblastic leukemia, acute myeloid leukemia, and Burkitt lymphoma.(4) There are also reports of TLS associated with cytotoxic chemo and radiation therapies.”
BackgroundReconocimiento y prevención del síndrome de lisis tumoral
Kaplow, R., & Iyere, K. (2017) · Nursing (Ed española) · doi:10.1016/j.nursi.2017.07.008 · Cited by 1
Tyrosine kinase inhibitors may change the metastatic pattern.
Şendur, M. A. N., Aksoy, S., Özdemir, N., & Zengin, N. (2013) · PubMed · Cited by 1
Efficacy of Rasburicase on Hyperuricemia in Adult Patients with Malignant Tumor
정지운, 김향숙, 이용화, 이혜숙, 김영애, & 조은정 (2014) · Journal of Korean Society of Health-System Pharmacists · doi:10.32429/jkshp.2014.31.6.005 · Cited by 1
Notfälle unter medikamentöser Tumortherapie
Alig, A. H. S., von Bergwelt, M., & Gießen-Jung, C. (2019) · Der Onkologe · doi:10.1007/s00761-019-00672-x · Cited by 1
Special Considerations for ICU Management of Patients Receiving CAR Therapy
Mahadeo, K. M., Tambaro, F. P., & Gutiérrez, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66181-2.00006-8 · Cited by 1
Ho, M., Zanwar, S., Duggan, P., Carr, R. M., Habermann, T. M., Navin, P. J., Salama, M. E., & Parikh, S. A. (2021) · American Journal of Hematology · doi:10.1002/ajh.26383 · Cited by 1
“4 kg of bone marrow that could “hide” tumor burden significant enough to cause spontaneous TLS, and an abundant amount could also exist in the intravascular space.(2) There have been multiple case reports of spontaneous TLS in patients with multiple myeloma (MM), as well as bone marrow infiltrating acute lymphoblastic…”
BackgroundHossen, M., Rabbani, R. D., & Hasan, M. A. (2014) · Journal of Bangladesh College of Physicians and Surgeons · doi:10.3329/jbcps.v31i3.20982 · Cited by 1
Prävention der Harnsäurenephropathie
Alsdorf, W. H., Sökler, M., & Bokemeyer, C. (2021) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_290-1 · Cited by 1
Bieber, S. D., & Jefferson, J. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47871-7.00047-2 · Cited by 1
Lee, D. L. Y. (2014) · Wiley eBooks · doi:10.1002/9781118673768.ch2 · Cited by 1
Therapeutic Approaches to Burkitt’s Lymphoma
Armitage, J. O., & Coulter, D. W. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4313-1_14 · Cited by 1
“More recently, some authors have suggested changes to the LTLS and CTLS de fi nitions, speci fi cally that two or more metabolic abnormalities be present simultaneously to denote LTLS, and a 25% change from baseline should not be considered a criterion for CTLS [ 53 ] .”
BackgroundAl‐Anazi, K. A. (2015) · InTech eBooks · doi:10.5772/61827 · Cited by 1
“It requires urgent treatment with aggressive hydration, correction of electro‐ lytic abnormalities and reduction of elevated uric acid levels [26,29,30].”
BackgroundMaekawa, T., Take, J., Kawamura, T., Horiuchi, T., Kato, S., & Saga, R. (2016) · Journal of Case Reports · doi:10.17659/01.2016.0015 · Cited by 1
“TLS can be classified into either laboratory type, defined as two or more of the following metabolic abnormalities (hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia) occurring within 3 days before, or up to 7 days after the initiation of treatment, or clinical type TLS, defined as laboratory TLS accomp…”
BackgroundInauen, R. I., Taverna, C., & Benz, R. A. (2013) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2013.01590 · Cited by 1
Kim, H. (2016) · Pediatric Emergency Medicine Journal · doi:10.22470/pemj.2016.3.2.37 · Cited by 1
An untreatable dyspnoea: more defendants under investigation
Ferrarese, A., Bergamo, F., Calabrese, F., Girolami, B., Iovino, S., Lonardi, S., Nannini, N., Vio, S., Zola, E., Vianello, A., et al. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1632-x · Cited by 1
“Another pathogenetic mechanism could be hypothesized in our patient, as precipitating cause of the worsening clinical course: chemotherapy-related massive necrosis of liver metastases leading to a ‘‘tumor lysis syndrome’’ with release of mediators and cytokines causing a systemic inflammatory response syndrome and mul…”
BackgroundSíndrome de lisis tumoral en adultos : revisión de la literatura.
Galvis, L., González, D., Jurado, N., & Sánchez, J. (2016) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.150 · Cited by 1
Hyperuricemia: A risk factor for the development and progression of chronic kidney disease
Petrović, D., Tirmenštajn‐Janković, B., Živanović, M., Petrovic-Nikolic, A., Nikolić, A., Jovanović, M., & Poskurica, M. (2016) · Timocki medicinski glasnik · doi:10.5937/tmg1604319p · Cited by 1
Ishibashi, M. (2017) · Journal of Japanese Society of Oral Oncology · doi:10.5843/jsot.29.78 · Cited by 1
Cardiac Tumors: Multimodality Approach, Follow-Up, and Prognosis
Paoli, A. D., Miolo, G., & Buonadonna, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-40236-9_25 · Cited by 1
SFAR—SRLF, R. C., de réanimation, S. F. D. E., française, S. D. R. D. L., sociétés GFRUP, S., pédiatriques, G. F. D. R. E. U., de néphrologie, S. F., Ichaï, C., Vinsonneau, C., Souweine, B., Canet, E., et al. (2017) · Médecine Intensive Réanimation · doi:10.1007/s13546-017-1310-z · Cited by 1
Morita, M., Oiwa, K., Fujita, K., Negoro, E., Okura, M., Matsuda, Y., Tai, K., Hosono, N., Kawamichi, M., Ueda, T., et al. (2017) · GOUT AND NUCLEIC ACID METABOLISM · doi:10.6032/gnam.41.183 · Cited by 1
What the Intensivists Need to Know About Critically Ill Lymphoma Patients
Nair, R. K., & Patel, K. K. (2019) · Springer eBooks · doi:10.1007/978-3-319-74588-6_97 · Cited by 1
Rastegar, M., Kitchlu, A., & Shirali, A. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-54945-5.00039-4 · Cited by 1
Hepatic Portoenterostomy; Kasai Procedure
Baijal, R. G., & Patel, N. V. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.028 · Cited by 1
Chun, Y., & King, M. R. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.026 · Cited by 1
Efficacy of a Reduced-dose Rasburicase: Single-institution Experience in India
Lakshmaiah, K., Babu, G., Rajeev, L. K., Loknatha, D., Abraham, L. J., Babu, M., Lokesh, K. N., Rudresha, A. H., & Agarwal, A. (2019) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/ijmpo.ijmpo_189_16 · Cited by 1
Distraction Techniques for Pediatric Pain Management
Kao, G. S., & Schwartz, E. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.058 · Cited by 1
Berkelhamer, M. C., & Rubin, K. P. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.033 · Cited by 1
Recent Advances and Surgical Applications of Monoclonal Antibodies
Elnemr, S., Sultan, A. A. E. A., & Nassar, S. M. S. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.62667 · Cited by 1
Tailakh, M. A., Yahia, A., Polischuck, I., & Liel, Y. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0349 · Cited by 1
César, B. N., Nunes, N. E. D., Hazin, M. A. A., Foresto, R. D., Kirsztajn, G. M., & Durão, M. S. (2020) · Journal of Onco-Nephrology · doi:10.1177/2399369320945718 · Cited by 1
Müller, J., Kalbermatten, N., Traichel, B., & Taverna, C. (2020) · Praxis · doi:10.1024/1661-8157/a003527 · Cited by 1
Minbiziaren aurkako CAR-T zelulen bidezko immunoterapia
García-Gallastegui, P., Basauri, M. M., & Arruabarrena, O. C. (2021) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.21946 · Cited by 1
“Bestalde, tumore zelulen bat-bateko suntsipenak tumore lisiaren sindromea ekar dezake (TLS, tumor lysis syndrome) [16].”
BackgroundThe intersection of oncology, nephrology, and palliative care
Corona, A. G. D. L., & Koncicki, H. M. (2021) · Journal of Onco-Nephrology · doi:10.1177/23993693211001380 · Cited by 1
Metformin restores cisplatin cytotoxicity reduced by allantoin in CML in vitro
Paz, G. S., de Amorim, G. C., & Fernandes, J. (2021) · World Academy of Sciences Journal · doi:10.3892/wasj.2021.116 · Cited by 1
Prevention, diagnosis and treatment of tumor lysis syndrome
Piwoński, M., Żak, K., Niedobylski, S., & Stanicki, P. (2021) · Journal of Education Health and Sport · doi:10.12775/jehs.2021.11.09.027 · Cited by 1
Case Studies in Pediatric Anesthesia
(2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736 · Cited by 1
Adler, A. C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.062 · Cited by 1
Chowdhury, D., & Kodavatiganti, R. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.068 · Cited by 1
Parchmont, E. C., & Adler, A. C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.039 · Cited by 1
Evans, R. E., & Ryan, W. D. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.005 · Cited by 1
Adler, A. C., & Teng, H. C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.048 · Cited by 1
Adler, A. C. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108668736.022 · Cited by 1
Acute Tumor Lysis Syndrome: A Review of 100 Patients with Acute Lymphoblastic Leukemia
Afrin, T., Yunus, A. B. M., Aziz, A., Sharmin, M., Shah, S., Kabir, A. L., Masud, M. A. H., Islam, S., & Islam, K. M. K. (2022) · Saudi Journal of Medical and Pharmaceutical Sciences · doi:10.36348/sjmps.2022.v08i04.007 · Cited by 1
Chitsike, I., & Howard, S. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3891-5_9 · Cited by 1
Self-citationAguilar, A. E., Agrawal, A. K., & Feusner, J. H. (2014) · Pediatric oncology · doi:10.1007/978-3-662-44317-0_6 · Cited by 1
Tay, H. M. (2014) · Proceedings of Singapore Healthcare · doi:10.1177/201010581402300105 · Cited by 1
Hematolog Olmayanlar için Çocukluk Çağında Akut Löseminin Tanısal İpuçları
Koç, B. Ş., Tekkeşin, F., Merter, T., Yıldırım, Ü., Asarcıklı, F., Aydoğdu, S., & Kılıç, S. Ç. (2022) · Çocuk Dergisi / Journal of Child · doi:10.26650/jchild.2022.1054469 · Cited by 1
Spontaneous Tumour Lysis Syndrome in Mantle Cell Lymphoma: A Case Study
Taha, N., & Bhaskar, G. (2022) · Cureus · doi:10.7759/cureus.29851 · Cited by 1
“This may lead to the deposition of calcium phosphate crystals in organs such as the kidneys, leading to acute kidney injury [10].”
BackgroundZhang, B., Liu, Q., Li, J., Hu, Y., Zhao, X., Huang, P., Li, S., & Wang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1193874 · Cited by 1
“The day of PLT recovery (> 20 × 10(9)/L) 16 (9-20) 16 (12-34) 0.”
Bae, S. S., Rasmussen, S., & Plemel, D. J. A. (2023) · Orbit · doi:10.1080/01676830.2023.2240410 · Cited by 1
Cough, Neck Pain, and Right Facial Paralysis in a 14-year-old with Autism
Hu, Z., Muller, B., Slone, J. S., & Inaba, H. (2024) · Pediatrics in Review · doi:10.1542/pir.2022-005512 · Cited by 1
Effect of Prostate Cancer on Non-protein Nitrogenous Substances
Chauhan, A., Atri, R., Dahiya, K., Pal, S., Kumar, H., & Gaur, S. (2024) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0219 · Cited by 1
Più Onco che Ematologia: botta, risposta e sottolineature attraverso i casi
Peccatori, N., Limido, F., Faraguna, M. C., Dagri, A., Coslovich, S., Marchettini, E., Rocco, E. M., Tessitore, A., & Biondi, A. (2024) · Medico e Bambino · doi:10.53126/meb43095 · Cited by 1
Ugwendum, D. F., Fernando, A., Agbor, D. B. A., Ndemazie, N. B., Forsah, S. F., Okorie, I. J., Villanueva, K., Grigos, A., & Nfonoyim, J. M. (2024) · Cureus · doi:10.7759/cureus.54088 · Cited by 1
“Our patient was on allopurinol because BL has a high rate of cellular proliferation and cellular turnover thus tumor lysis syndrome which is characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia [27].”
BackgroundSzász, R., & Pálfi, T. G. (2024) · Hematológia–Transzfuziológia · doi:10.1556/2068.2024.00185 · Cited by 1
Kamel, A., Sanders, M., Dyk, H., & Hamilton, T. (2024) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552241253214 · Cited by 1
bakhsh, S. E., Khan, M. A., Alshamrani, M. A., Mufti, R., Naeem, A., Almubarak, M., Alsaeed, A. S., Alahmari, M. S., & Aseeri, M. A. (2024) · Cureus · doi:10.7759/cureus.68664 · Cited by 1
Ngo, H., Oh, E., Li, C., & Yu, J. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.08.020 · Cited by 1
Huang, I. J., Baek, G., Cohen, J., Khajavian, S., Louie, S., Samples, L. S., Smith, S. D., Till, B. G., Warren, E. H., Gopal, A. K., et al. (2024) · JCO Oncology Practice · doi:10.1200/op.24.00416 · Cited by 1
Lin, L. Y.-C., Filtz, M. R., Wilson, J., Errigo, R., Zuromski, L. M., Sorenson, A. H. T. N., & Young, B. A. (2024) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae139 · Cited by 1
Anuric Acute Kidney Injury in Chronic Myeloid Leukemia: A Rare Complication Case.
Tjahjadi, A. K., & Tjempakasari, A. (2024) · Acta medica Indonesiana · Cited by 1
Bell, C. S., Chaffee, R., Lou, U. Y., Luk, S. O., & Tavares, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_35 · Cited by 1
MUCOSITE ORAL EM PACIENTES PEDIÁTRICOS ONCOLÓGICOS
PEREIRA, L. F., & Arid, J. (2025) · Revista Científica Unilago · Cited by 1
Metadata
- Authors
- Howard, S. C., Jones, D. P., & Pui, C.-H.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-05-12
- Volume
- 364
- Issue
- 19
- Pages
- 1844-1854
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3437249
- OpenAlex
- W2122479144
- Cited by
- 1,044
- References
- 58
- Citations by year
- 2026: 71 · 2025: 67 · 2024: 86 · 2023: 71 · 2022: 69 · 2021: 81 · 2020: 89 · 2019: 154 · 2018: 60 · 2017: 53 · 2016: 49 · 2015: 57 · 2014: 47 · 2013: 49 · 2012: 31
- FWCI
- 36.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA21765, P30CA021765)
- National Institute of General Medical Sciences (U01GM92666, U01GM092666)
- Topics
- Health Sciences › Medicine › Hematology › Methemoglobinemia and Tumor Lysis Syndrome
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Surgery › Muscle and Compartmental Disorders
- Keywords
- tumor lysis syndrome, hematologic malignancies, risk assessment, prophylaxis, treatment, pediatric oncology, emergency management
- MeSH terms
- Child, Humans, Male, Tumor Lysis Syndrome, Risk Assessment, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.